Overview
Louay Hanna is an Oncologist and a Hematologist in Hickory, North Carolina. Dr. Hanna is rated as an Experienced provider by MediFind in the treatment of Clear Cell Sarcoma. His top areas of expertise are Thrombocytopenia, Paget Disease of the Breast, Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration. Dr. Hanna is currently accepting new patients.
His clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- POS
- PPO
Locations
2406 Century Pl Se, Hickory, NC 28602
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Atrium Health Levine Cancer Institute (Medical Oncology & Immunotherapy)
Asim Amin is an Oncologist in Charlotte, North Carolina. Dr. Amin is rated as an Elite provider by MediFind in the treatment of Clear Cell Sarcoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Melanoma, Chromophobe Renal Cell Carcinoma, and Clear Cell Sarcoma. Dr. Amin is currently accepting new patients.
Novant Health Cancer Institute - Forsyth (Medical Oncology)
Timothy Collins is a Hematologist and an Oncologist in Winston Salem, North Carolina. Dr. Collins is rated as a Distinguished provider by MediFind in the treatment of Clear Cell Sarcoma. His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, Familial Prostate Cancer, Adult Soft Tissue Sarcoma, and Nephrectomy.
Atrium Health Levine Cancer Institute (GI/Gastrointestinal Cancer)
Earle Burgess is an Oncologist in Charlotte, North Carolina. Dr. Burgess is rated as a Distinguished provider by MediFind in the treatment of Clear Cell Sarcoma. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, and Chromophobe Renal Cell Carcinoma. Dr. Burgess is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Lymphocytic Leukemia (CLL)Dr. Hanna isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Colorectal CancerDr. Hanna isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Hanna isDistinguished. Learn about Familial Colorectal Cancer.
- Lung CancerDr. Hanna isDistinguished. Learn about Lung Cancer.
- Paget Disease of the BreastDr. Hanna isDistinguished. Learn about Paget Disease of the Breast.
- Pleuropulmonary BlastomaDr. Hanna isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- Adult Immune ThrombocytopeniaDr. Hanna isAdvanced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Hanna isAdvanced. Learn about Agranulocytosis.
- AnemiaDr. Hanna isAdvanced. Learn about Anemia.
- Breast CancerDr. Hanna isAdvanced. Learn about Breast Cancer.
- Carcinoid SyndromeDr. Hanna isAdvanced. Learn about Carcinoid Syndrome.
- Childhood Acute Myeloid Leukemia
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Acute Eosinophilic PneumoniaDr. Hanna isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Hepatic Porphyria (AHP)Dr. Hanna isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Intermittent PorphyriaDr. Hanna isExperienced. Learn about Acute Intermittent Porphyria.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation


